How do peptides work?
How do peptides work? These mechanism articles are the how behind the what. If you want to understand what a GLP-1 dual agonist actually does after injection, why a growth hormone peptide works with your pituitary instead of around it, or which receptor a molecule binds — this is that shelf.
Written to be understood like you're fifteen, sourced from the primary literature, and honest wherever the mechanism is still a hypothesis rather than settled science.
147 articles on this topic
-
Semaglutide Pyridoxine: What Vitamin B6 Adds
Semaglutide/pyridoxine is a compounded combination of semaglutide and vitamin B6. Some compounders add B6 with nausea in mind, but no clinical trial has shown that the combination reduces GLP-1 nausea.
-
Sermorelin for Men: Testosterone, Muscle & Sleep
Sermorelin can stimulate growth-hormone release when the pituitary responds, but it is not testosterone therapy. Small studies in older men found biochemical changes and mixed body-composition or strength results, with no reliable sleep or recovery benefit established.
-
Sermorelin Tablets: Do Oral Forms Work?
Tablets, troches and rapid-dissolve forms sound simpler than an injection. The unresolved question is whether they deliver intact sermorelin into the bloodstream in a reliable amount.
-
BPC-157 Half-Life: What the Evidence Shows
The human half-life of BPC-157 has not been established. Animal studies measured the intact peptide in minutes, not hours, while detection tests and biological effects answer different questions.
-
KPV Peptide Benefits: What the Evidence Shows
KPV's strongest benefit signals are lower inflammatory activity in cultured cells and mouse colitis models. No human trial has established a KPV benefit, dose, or safety profile.
-
Semaglutide Glycine: Why Some Pharmacies Add It
Semaglutide with glycine is a compounded combination. Glycine may be described as a formulation aid or wellness additive, but no clinical trial shows that the pairing improves semaglutide outcomes.
-
Sermorelin for Weight Loss: What Studies Show
Sermorelin is not a weight-loss drug. It changes growth-hormone signaling, but small older-adult studies found hormone effects without reliable scale-weight loss.
-
Tesamorelin vs CJC-1295: Evidence and Differences
Both peptides signal through the GHRH receptor, but their structures, duration and human evidence differ sharply. The clearest distinction is phase 3 visceral-fat data for tesamorelin versus biomarker studies for CJC-1295.
-
Thymosin Alpha-1 Benefits: What Studies Show
Thymosin alpha-1 has a credible immune-modulating mechanism, but its human evidence is condition-specific and mixed. The strongest trials do not support a blanket promise of stronger immunity.
-
Tirzepatide for Weight Loss: What to Know
Tirzepatide for weight loss is a once-weekly prescription treatment studied alongside diet and physical activity. Here is who SURMOUNT-1 enrolled, what it found, and what long-term care involves.
-
BPC-157 Benefits: What the Evidence Actually Shows
BPC-157 has been studied across connective tissue, gut, inflammatory, nerve, and vascular models. The catch is decisive: most findings come from animals or cells, not controlled human trials.
-
Is Semaglutide the Same as Ozempic?
Ozempic is a Novo Nordisk product that contains semaglutide. Compounded semaglutide may name the same base molecule, but it is not Ozempic and the finished products are not interchangeable.
-
KLOW Peptide Benefits: What Each Component Adds
KLOW brings four peptide research rationales into one compounded formulation. The evidence runs from cell studies to animal models, but no clinical trial has tested the finished blend.
-
Semaglutide for Weight Loss: What It Involves
Semaglutide for weight loss is a prescription treatment used alongside lower-calorie eating and physical activity. Its effects build over months, and individual results depend on continued treatment, tolerability, and clinical fit.
-
Sermorelin Injections: Sites and Expectations
Sermorelin is injected into the fatty layer beneath the skin, commonly around bedtime. The dose, schedule, site plan, and storage instructions come from the prescriber and dispensing pharmacy—not a universal online protocol.
-
SS-31 Benefits: What Human Trials Actually Show
The clearest human evidence for SS-31 is narrow: muscle-strength findings in people with Barth syndrome. Larger trials in other mitochondrial, heart, and eye conditions have produced mixed or negative primary results.
-
TB-500 Benefits: What the Evidence Shows
TB-500 benefits are biologically plausible but not established in people. Direct evidence is largely laboratory and animal work on a related actin-binding sequence; the human eye and wound trials tested full-length thymosin beta-4, not systemic TB-500.
-
Foods to Avoid on Tirzepatide: A Practical Guide
There is no universal ban list. Smaller portions and fewer fried, high-fat, fizzy, or alcohol-heavy choices may make nausea, reflux, bloating, and fullness easier to manage.
-
How Long Do Peptides Take to Work?
Peptide timelines range from hours on a lab test to months on a scale. The useful answer depends on the molecule, the outcome being measured and the quality of the evidence behind it.
-
Semaglutide for Fatty Liver: What Evidence Shows
Semaglutide has strong biopsy-based evidence in adults with MASH and F2–F3 fibrosis. That is narrower than “fatty liver,” and it does not make every semaglutide formulation interchangeable.
Page 5 of 8 · 147 articles